A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies. - Wikidata - awgldk - TriplyDB

A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.

A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.

http://www.wikidata.org/entity/Q37036934

about

Rare case of pancreatic cancer with leptomeningeal carcinomatosis Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy.A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis.Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors.Reversible occlusion (on-off) valves in shunted tumor patients.Carcinomatous meningitis in non-small cell lung cancer: Palliation with intrathecal treatment.Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials Neoplastic meningitis from solid tumors: new diagnostic and therapeutic approaches.Leptomeningeal metastases: a RANO proposal for response criteria.Leptomeningeal Metastasis: Challenges in Diagnosis and Treatment A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study.Carcinomatous meningitis: Leptomeningeal metastases in solid tumors Intrathecal chemotherapy as a treatment for leptomeningeal metastasis of non-small cell lung cancer: A pooled analysis Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment.Anticancer therapies and CNS relapse: overcoming blood-brain and blood-cerebrospinal fluid barrier impermeability.Intra-CSF administration of chemotherapy medications.State of the art of chemotherapy for the treatment of central nervous system metastases from non-small cell lung cancer.Meningeal carcinomatosis: a metastasis from gastroesophageal junction adenocarcinoma.Intraventricular topotecan for the treatment of neoplastic meningitis: five case studies.Treatment of leptomeningeal spread of NSCLC: a continuing challenge.Treatment of Leptomeningeal Carcinomatosis in a Patient with Metastatic Pancreatic Cancer: A Case Report and Review of the Literature.

P2860

Q28082817-98EF9BEF-D58B-4E05-A51A-EF8563878607 Q30251581-D4FD7B25-5602-451F-B521-300F04E56156 Q30641737-8AAD20AB-5103-4199-91F2-8C9A523BDE12 Q33387996-FA68C3EA-4875-475B-A111-0DC66251C4CC Q33755797-5076EA2F-FA4A-4531-94AA-922D486B90E4 Q33841560-3BB123C1-96C5-43DD-9CD7-74230CAC3CC8 Q35175149-84C1F3CF-2452-4FFC-9813-6015D113274D Q35584731-ED7AB40F-3E0F-4FC5-9193-B3884F195AA6 Q36236770-100FA799-8363-435C-9CD7-A7E211B5188A Q36469191-F0C29BCE-0495-4F98-B862-002EE373CB67 Q36612172-54CFAE1B-C476-427D-8759-C9518501B107 Q36851197-1BDDA085-D97C-4EB2-BD89-E656F7469C90 Q37107954-7F7FE9F1-2E44-48E5-BF3E-C952A222E859 Q37394649-45C03B12-E991-497C-81F0-76BAC9BAE272 Q37690311-AD17150A-A3B3-452E-93A1-46E7F0D77EEC Q37724215-7B97426F-0ECB-40C7-88B5-6A8A0BB16BB7 Q38015719-26DB198C-FDEA-4CB9-98A4-2B4ED27EDF16 Q38985340-7C807433-E88C-4C6D-9DAF-A665E2CE512E Q41850542-43752F7D-2D77-40FD-98FC-4C5C4B6D3D0A Q42731826-030880B6-84DA-4168-AAC5-6FAB408D5C76 Q48427334-21F8AFFC-D0B4-4022-B3B9-340C04BB79F8 Q55260250-C9E27852-49C9-477E-8B62-07C3C674F347

P2860

A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.

http://www.wikidata.org/entity/Q37036934

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A multicenter phase II trial o ...... s with meningeal malignancies.

@en

A multicenter phase II trial o ...... s with meningeal malignancies.

@nl

type

label

A multicenter phase II trial o ...... s with meningeal malignancies.

@en

A multicenter phase II trial o ...... s with meningeal malignancies.

@nl

prefLabel

A multicenter phase II trial o ...... s with meningeal malignancies.

@en

A multicenter phase II trial o ...... s with meningeal malignancies.

@nl

P1433

Q37036934-4A2B73D1-4E42-4514-AC99-3A2B1CADAC04

P1476

Q37036934-CA84A16E-8AFB-4F8E-8587-FFBABFCF25B3

P2093

Q37036934-041305B9-03F5-4A24-A302-76BCD49BE63C

Q37036934-2F2829EF-56D0-489A-95D1-EA48BE6E05F9

Q37036934-3C4A9DED-3232-46DB-92FB-463EC92B0C08

Q37036934-3CB1C665-B2F2-4B86-A6C9-17CD7069495B

Q37036934-412E0138-46A9-467D-9550-AD41125E60BD

Q37036934-46E4F95F-259C-4952-A44F-27A7992CF448

Q37036934-64938E0E-8A9C-463E-B703-5E1CF233E6FA

Q37036934-661BE15B-9A16-4972-8A16-F44852227203

Q37036934-6F000B13-1E4B-4AAA-8AC7-AD26ADF0AF18

Q37036934-7D552D67-3182-440A-8E16-CCF620EAD435

P2860

Q37036934-1103779C-F72C-4F1C-A7A7-EC0379D6771F

Q37036934-1448E65C-EE73-4377-9EFE-1F8541FA8B1A

Q37036934-22C26076-0276-4860-A34D-AA90C74F191C

Q37036934-2E027B00-92EE-4AD9-9876-34BCDB4D26C0

Q37036934-35FCE2EC-BB8F-459D-8369-16B0E3C55786

Q37036934-59C9332D-4B2C-4D12-9CE0-E06D0D69F451

Q37036934-89797659-E03C-4EEA-816B-48F4E743F7A6

Q37036934-90CF6C37-A6B9-487B-9776-47C636390750

Q37036934-9FD347D1-4C79-4B16-A421-874693B11D98

Q37036934-A2BB9C05-FB0E-431F-8AE4-D6F706CA3994

P304

Q37036934-E25BA3C6-190C-4A47-AADE-3116110DCF98

P31

Q37036934-96C4DA89-6D1F-48DB-B69B-91715DC01365

P356

Q37036934-4F484A8A-571F-4262-89F6-6EF1787E3B1C

P433

Q37036934-4CE226E0-B8D3-43CD-9B70-C5AD865E0824

P478

Q37036934-2245CF1A-D570-40A6-A4D7-6524936D5C13

P577

Q37036934-C9DE1A80-5932-47D0-9496-2AF467AC4C15

P5875

Q37036934-E34EF7C0-0A53-4BC2-8C25-75FAC0246EBF

P698

Q37036934-05B534D8-DD0E-4810-B6D3-AD443023F5CB

P921

Q37036934-9CE6DB66-7310-4F43-8E24-6BACD6302D70

Q37036934-C73FCA22-2EC7-4C26-9B18-3F46F390CD21

P932

Q37036934-6BEF0AB7-D3FC-4BBB-BFDD-3E2AB4399753

P356

15228517-2007-059

P1433

P1476

A multicenter phase II trial o ...... s with meningeal malignancies.

@en

P2093

Arthur D Forman

http://www.w3.org/2001/XMLSchema#string

Charles A Conrad

http://www.w3.org/2001/XMLSchema#string

Howard Colman

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Wefel

http://www.w3.org/2001/XMLSchema#string

Karen E Baumgartner

http://www.w3.org/2001/XMLSchema#string

Kathy U Hunter

http://www.w3.org/2001/XMLSchema#string

Kenneth R Hess

http://www.w3.org/2001/XMLSchema#string

Marc C Chamberlain

http://www.w3.org/2001/XMLSchema#string

Mark R Gilbert

http://www.w3.org/2001/XMLSchema#string

Michael J Glantz

http://www.w3.org/2001/XMLSchema#string

P2860

Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine

Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

Cytotoxic activity of topotecan in human tumour cell lines and primary cultures of human tumour cells from patients.

Update on planning of phase II clinical trials.

Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis.

Meningeal carcinomatosis from breast cancer: spinal cord vs. brain involvement.

Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment.

An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis.

Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors.

P304

208-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1215/15228517-2007-059

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5536715

http://www.w3.org/2001/XMLSchema#string

P698

18316473

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

multicenter trial

P932

2613823

http://www.w3.org/2001/XMLSchema#string